International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic dataDaniel A. Arber, Michael R. Savona, Katherine R. Calvo et al.|Blood|2022Cited by 2.7k
An open-label phase 2 study of glycogen synthase kinase-3 inhibitor LY2090314 in patients with acute leukemiaDavid A. Rizzieri, Gautam Borthakur, Olatoyosi Odenike et al.|Leukemia & lymphoma/Leukemia and lymphoma|2016Cited by 78